Beta-adrenoreceptor blockade abolishes atomoxetine-induced risk taking

Atomoxetine boosted NE levels and increased risk taking. This was because atomoxetine decreased rats' sensitivity to losses. These effects were likely mediated by beta-adrenoreceptor.